PHOSPHOPROTEOMIC ANALYSIS OF SECOND GENERATION CHIMERIC ANTIGEN RECEPTOR SIGNALLING FOR THE TREATMENT OF GLIOBLASTOMA

被引：0
|
作者：
Cross, R. [1 ]
Sandow, J. [2 ]
Pires, D. [3 ]
Yousef, J. [2 ]
Iliopoulos, M. [1 ]
Webb, A. [2 ]
Jenkins, M. [1 ]
机构：
[1] Walter & Eliza Hall Inst Med Res, Immunol, Parkville, Vic, Australia
[2] Walter & Eliza Hall Inst Med Res, Prote, Parkville, Vic, Australia
[3] Univ Melbourne, Bio21, Parkville, Vic, Australia
来源：
HUMAN GENE THERAPY | 2023年 / 34卷 / 21-22期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P087
引用
收藏
页码：A38 / A38
页数：1
相关论文
共 50 条
  • [1] Commentary: Chimeric Antigen Receptor T-Cell Therapy: Updates in Glioblastoma Treatment GLIOBLASTOMA: A CASE FOR CHIMERIC ANTIGEN RECEPTOR T CELLS
    Yu, Xiaoling
    Curry, William T.
    Gerstner, Elizabeth R.
    Cahill, Daniel P.
    Nahed, Brian V.
    Maus, Marcela V.
    Carter, Bob S.
    Choi, Bryan D.
    [J]. NEUROSURGERY, 2021, 89 (01) : E68 - E69
  • [2] Allogeneic EGFRvIII chimeric antigen receptor T cells for treatment of glioblastoma
    Wong, Oi Kwan
    Dusseaux, Mathilde
    Ma, Jing-Tyan
    Au, Melinda
    Leduc, Sophie
    Chou, Joyce
    Yu, Jessica M.
    Bateman, Marjorie
    Pertel, Thomas
    Lindquist, Kevin C.
    Smith, Julianne
    Sasu, Barbra
    Liu, Shu-Hui
    [J]. CANCER RESEARCH, 2017, 77
  • [3] Chimeric Antigen Receptor T-Cell Therapy: Updates in Glioblastoma Treatment
    Feldman, Lisa
    Brown, Christine
    Badie, Behnam
    [J]. NEUROSURGERY, 2021, 88 (06) : 1056 - 1064
  • [4] Phase I Study of Second Generation Chimeric Antigen Receptor-Engineered T Cells Targeting IL13Rα2 for the Treatment of Glioblastoma
    Brown, Christine E.
    Starr, Renate
    Weng, Lihong
    Alizadeh, Darya
    Wagner, Jamie R.
    Kilpatrick, Julie
    Harshbarger, Todd L.
    D'Apuzzo, Massimo
    Ressler, Julie A.
    Jensen, Michael C.
    Portnow, Jana
    Barish, Michael E.
    Forman, Stephen J.
    Badie, Behnam
    [J]. MOLECULAR THERAPY, 2016, 24 : S97 - S97
  • [5] A BISPECIFIC CHIMERIC ANTIGEN RECEPTOR TARGETING ANTIGEN ESCAPE VARIANTS IN GLIOBLASTOMA
    Hegde, M.
    Corder, A.
    Grada, Z.
    Byrd, T. T.
    Chow, K. K.
    Brawley, V. S.
    Krebs, S. S.
    Heslop, H.
    Gottschalk, S.
    Yvon, E.
    Ahmed, N.
    [J]. CYTOTHERAPY, 2014, 16 (04) : S28 - S28
  • [6] Phosphoproteomic analysis of chimeric antigen receptor signaling reveals kinetic and quantitative differences that affect cell function
    Salter, Alexander I.
    Ivey, Richard G.
    Kennedy, Jacob J.
    Voillet, Valentin
    Rajan, Anusha
    Alderman, Eva J.
    Voytovich, Uliana J.
    Lin, Chenwei
    Sommermeyer, Daniel
    Liu, Lingfeng
    Whiteaker, Jeffrey R.
    Gottardo, Raphael
    Paulovich, Amanda G.
    Riddell, Stanley R.
    [J]. SCIENCE SIGNALING, 2018, 11 (544)
  • [7] The pharmacology of second-generation chimeric antigen receptors
    van der Stegen, Sjoukje J. C.
    Hamieh, Mohamad
    Sadelain, Michel
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2015, 14 (07) : 499 - 509
  • [8] The pharmacology of second-generation chimeric antigen receptors
    Sjoukje J. C. van der Stegen
    Mohamad Hamieh
    Michel Sadelain
    [J]. Nature Reviews Drug Discovery, 2015, 14 : 499 - 509
  • [9] Chimeric Antigen Receptor T-Cell Therapy for Glioblastoma
    Ma, Kun
    Hu, Ping
    [J]. CANCERS, 2023, 15 (23)
  • [10] Cytokine Modification of Adoptive Chimeric Antigen Receptor Immunotherapy for Glioblastoma
    Pawlowski, Kristen D.
    Duffy, Joseph T.
    Gottschalk, Stephen
    Balyasnikova, Irina V.
    [J]. CANCERS, 2023, 15 (24)
12345